CVRx (CVRX) Gross Margin (2020 - 2026)

CVRx's (CVRX) quarterly Gross Margin came in at 87.22% in Q1 2026, up 370.0% year-on-year from 18.56% in Q1 2025, and up 1.09% quarter-over-quarter from 86.28% in Q4 2025.

CVRx (CVRX) Gross Margin (2020 - 2026) Analysis & Trends

CVRx's Gross Margin history runs 7 years deep, the most recent figure standing at 87.22% for Q1 2026.

  • On a quarterly basis, Gross Margin rose 370.0% year-over-year to 87.22% in Q1 2026; TTM through Mar 2026 was 86.18%, a 274.0% increase from a year earlier, with the FY2025 full-year figure at 85.33%, up 158.0% from the prior year.
  • Gross Margin improved to 87.22% in Q1 2026 per CVRX's latest filing, from 86.28% in the prior quarter.
  • Across five years, Gross Margin topped out at 87.22% in Q1 2026 and bottomed at 76.13% in Q2 2022.
  • The 5-year median for Gross Margin is 83.91% (2024), against an average of 82.92%.
  • Across the five-year window, Gross Margin jumped 790 bps in 2023 and slumped 154 bps in 2024, its largest moves.
  • Year by year, Gross Margin stood at 78.97% in 2022, then gained by 7 bps to 84.79% in 2023, then retreated by 2 bps to 83.24% in 2024, then increased by 4 bps to 86.28% in 2025, then advanced by 1 bps to 87.22% in 2026.
  • Per Business Quant, the three latest CVRX Gross Margin figures stand at 87.22% (Q1 2026), 86.28% (Q4 2025), and 86.81% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Abbott Laboratories 183.67 Bn 176.38 Bn 6.27 Bn 56.20%
2 Stryker 128.91 Bn 126.03 Bn 3.81 Bn 63.29%
3 Medtronic 108.84 Bn 99.62 Bn 6.41 Bn 65.35%
4 Boston Scientific 68.57 Bn 67.12 Bn 3.61 Bn 69.46%
5 Edwards Lifesciences 48.68 Bn 45.01 Bn 1.29 Bn 78.01%
6 Dexcom 28.42 Bn 27.31 Bn 750.30 Mn 62.95%
7 GE HealthCare Technologies 28.38 Bn 26.09 Bn 1.98 Bn 38.53%
8 Smith & Nephew 26.94 Bn 26.36 Bn - -
9 Koninklijke Philips 25.50 Bn 22.38 Bn 2.07 Bn 45.22%
10 CVRx 129.93 Mn 57.63 Mn 12.88 Mn 87.22%

Historic Data

Download Data
DateValue
Mar 31, 2026 87.22%
Dec 31, 2025 86.28%
Sep 30, 2025 86.81%
Jun 30, 2025 84.26%
Mar 31, 2025 83.51%
Dec 31, 2024 83.24%
Sep 30, 2024 83.19%
Jun 30, 2024 83.91%
Mar 31, 2024 85.00%
Dec 31, 2023 84.79%
Sep 30, 2023 83.91%
Jun 30, 2023 84.03%
Mar 31, 2023 83.36%
Dec 31, 2022 78.97%
Sep 30, 2022 78.34%
Jun 30, 2022 76.13%
Mar 31, 2022 76.72%
Dec 31, 2021 73.10%
Sep 30, 2021 74.20%
Jun 30, 2021 70.77%